[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Price Vision Group\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":68},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100657682","phase-2-corneal-crosslinking-for-treatment-of-progressive-keratoconus-or-corneal-ectasia-100657682",false,"NCT07841470","Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia","Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment","Inclusion Criteria:\n\n* Diagnosis of keratoconus or corneal ectasia\n* Provision of written informed consent\n\nExclusion Criteria:\n\n* Previous ocular condition in the study eye that may predispose for future complications including history of corneal disease (e.g., herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, corneal melt, corneal dystrophy, etc.)\n* Clinically significant corneal scarring in the proposed treatment zone\n* History of chemical injury or delayed epithelial healing in the study eye\n* Known sensitivity to study medication\n* A current condition, including clinically significant dry eyes or use of medications know to induce dry eye symptoms, that, in the treating physician's opinion, would interfere with or prolong epithelial healing\n* Pregnancy (including plan to become pregnant) or lactation during the course of the study","ALL","10 Years","90 Years",{"count":20,"type":21},500,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE2","PHASE3","This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.",[28,29],"Keratoconus","Corneal Ectasia",[31,32],"crosslinking","keratoconus","RECRUITING","2026-09-24",{"date":36,"type":37},"2026-09-25","ACTUAL",{"date":39,"type":37},"2025-10-01",{"date":41,"type":21},"2031-06-30",{"name":43,"class":44},"Price Vision Group","INDUSTRY",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":45},"100422948","phase-2-corneal-crosslinking-for-treatment-of-corneal-neovascularization-100422948","NCT04787471","Corneal Crosslinking for Treatment of Corneal Neovascularization","Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and\u002For Infection","Inclusion Criteria:\n\n* 18 years of age or older\n* With active inflammation or infection causing vascularization and possibly melting of the cornea, or vessels extending into the cornea causing lipid deposition, or vascularization that could significantly increase the risk of rejection of a current or planned corneal transplant, or vessels that continue to extend into the cornea despite topical treatment with corticosteroids.\n* Signed written informed consent.\n\nExclusion Criteria:\n\n* Known sensitivity to treatment medications\n* Current condition that in the investigator's opinion could compromise safety or data integrity.\n* Pregnancy (including plan to become pregnant) or lactation during the course of the study","18 Years",{"count":55,"type":21},138,[24,25],"The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without concomitant inflammation and\u002For infection.",[59],"Corneal Neovascularization","2026-09-14",{"date":62,"type":37},"2026-09-17",{"date":64,"type":37},"2021-05-03",{"date":66,"type":21},"2029-09-15",{"name":43,"class":44},""]